These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2952965)

  • 1. [Determination of platelet serotonin in obsessive-compulsive disorders].
    Cottraux J; Flachaire E; Renaud B; Sluys M
    Presse Med; 1987 Apr; 16(12):590. PubMed ID: 2952965
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
    Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
    Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal effects on platelet 5-HT content in patients with OCD and controls.
    Brewerton TD; Flament MF; Rapoport JL; Murphy DL
    Arch Gen Psychiatry; 1993 May; 50(5):409. PubMed ID: 8489330
    [No Abstract]   [Full Text] [Related]  

  • 4. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder.
    Altemus M; Murphy DL; Greenberg B; Lesch KP
    Am J Med Genet; 1996 Jul; 67(4):409-11. PubMed ID: 8837711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder.
    Cook EH; Charak DA; Arida J; Spohn JA; Roizen NJ; Leventhal BL
    Psychiatry Res; 1994 Apr; 52(1):25-33. PubMed ID: 8047619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder.
    Hanna GL; Yuwiler A; Coates JK
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):28-35. PubMed ID: 7860453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet alpha2-adrenoreceptors in obsessive-compulsive disorder.
    Marazziti D; Baroni S; Masala I; Giannaccini G; Mungai F; Di Nasso E; Cassano GB
    Neuropsychobiology; 2004; 49(2):81-3. PubMed ID: 14981338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
    Culebras Poza JM; Launay JM; Briere J; Dreux C
    Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder.
    Hanna GL; Himle JA; Curtis GC; Koram DQ; Veenstra-VanderWeele J; Leventhal BL; Cook EH
    Neuropsychopharmacology; 1998 Feb; 18(2):102-11. PubMed ID: 9430134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood obsessive-compulsive disorder.
    Rapoport J; Elkins R; Langer DH; Sceery W; Buchsbaum MS; Gillin JC; Murphy DL; Zahn TP; Lake R; Ludlow C; Mendelson W
    Am J Psychiatry; 1981 Dec; 138(12):1545-54. PubMed ID: 7304788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorder.
    Perez J; Tardito D; Ravizza L; Racagni G; Mori S; Maina G
    Am J Psychiatry; 2000 Feb; 157(2):284-6. PubMed ID: 10671404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonin concentration in schizophrenic patients.
    Kolakowska T; Molyneux SG
    Am J Psychiatry; 1987 Feb; 144(2):232-4. PubMed ID: 3812796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on platelet serotonin. I. Fluorimetric determination, reference values, 1st results].
    Launay JM; Dreux C
    Ann Biol Clin (Paris); 1973; 31(5):387-95. PubMed ID: 4775011
    [No Abstract]   [Full Text] [Related]  

  • 16. Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder.
    Grossman R; Cohen L; Rosen J; DeCaria C; Hollander E
    Biol Psychiatry; 1996 Jun; 39(11):982-5. PubMed ID: 9162213
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL; McCracken JT; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
    Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.
    Pigott TA; L'Heureux F; Rubenstein CS; Bernstein SE; Hill JL; Murphy DL
    J Clin Psychopharmacol; 1992 Jun; 12(3):156-62. PubMed ID: 1629380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopathological and peripheral levels of neurobiological correlates of obsessive-compulsive symptoms in patients with epilepsy: a hospital-based study.
    Hamed SA; Elserogy YM; Abd-Elhafeez HA
    Epilepsy Behav; 2013 May; 27(2):409-15. PubMed ID: 23541859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.